UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$1.48B |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$690M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$588M |
| 4 |
Truist Financial
TFC
|
+$532M |
| 5 |
VanEck Gold Miners ETF
GDX
|
+$278M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.3B |
| 2 |
Alibaba
BABA
|
+$771M |
| 3 |
AABA
Altaba Inc
AABA
|
+$759M |
| 4 |
STI
SunTrust Banks, Inc.
STI
|
+$503M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$467M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.82% |
| 2 | Financials | 7.38% |
| 3 | Healthcare | 6.65% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Industrials | 5.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PMBC
5526
DELISTED
Pacific Mercantile Bancorp
PMBC
| $227K | ﹤0.01% |
27,950
+6,051
| +28% | +$44.3K |
|
5527
Reading International Class A
RDI
$34.3M
| $226K | ﹤0.01% |
20,189
+7,965
| +65% | +$88.9K |
|
|
TARO
5528
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $226K | ﹤0.01% |
2,570
-2,215
| -46% | -$187K |
|
5529
Franklin Financial Services
FRAF
$280M
| $225K | ﹤0.01% |
5,830
+1,177
| +25% | +$42.9K |
|
5530
Oportun Financial
OPRT
$372M
| $225K | ﹤0.01% |
9,447
+8,284
| +712% | +$153K |
|
5531
CALL
DHT Holdings
DHT
$3.02B
| $224K | ﹤0.01% |
27,000
| – | – |
|
5532
CALL
Gold Fields
GFI
$36.5B
| $224K | ﹤0.01% |
34,000
| – | – |
|
|
PTN
5533
Palatin Technologies
PTN
$13.8M
| $224K | ﹤0.01% |
229
+86
| +60% | +$87.2K |
|
|
KRTX
5534
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $223K | ﹤0.01% |
2,962
-536
| -15% | -$23.5K |
|
5535
Fidelity High Dividend ETF
FDVV
$10.5B
| $222K | ﹤0.01% |
6,814
+6,464
| +1,847% | +$201K |
|
5536
Rockwell Medical
RMTI
$28.2M
| $221K | ﹤0.01% |
824
+332
| +67% | +$83.5K |
|
5537
United Therapeutics
UTHR
$23.1B
| $221K | ﹤0.01% |
2,516
-54,558
| -96% | -$4.8M |
|
5538
Harrow
HROW
$1.51B
| $220K | ﹤0.01% |
28,319
+2,821
| +11% | +$16.3K |
|
5539
Global X MSCI Norway ETF
NORW
$86.1M
| $220K | ﹤0.01% |
10,062
+3,951
| +65% | +$82.9K |
|
5540
First Trust Natural Gas ETF
FCG
$614M
| $219K | ﹤0.01% |
18,174
-21,066
| -54% | -$228K |
|
5541
HBT Financial
HBT
$1.32B
| $219K | ﹤0.01% |
+11,520
| New | +$196K |
|
5542
LG Display
LPL
$3.3B
| $219K | ﹤0.01% |
31,560
-246,968
| -89% | -$1.54M |
|
5543
NI Holdings
NODK
$320M
| $219K | ﹤0.01% |
12,749
+5,440
| +74% | +$93.3K |
|
5544
Urban Outfitters
URBN
$6.59B
| $219K | ﹤0.01% |
7,890
+4,445
| +129% | +$124K |
|
5545
Orion
OEC
$409M
| $218K | ﹤0.01% |
11,302
-10,622
| -48% | -$192K |
|
5546
CPI Card Group
PMTS
$320M
| $218K | ﹤0.01% |
241,790
-1,687
| -0.7% | -$2.54K |
|
5547
Invesco S&P 500 Downside Hedged ETF
PHDG
$65M
| $217K | ﹤0.01% |
7,760
-7,552
| -49% | -$205K |
|
5548
Invesco Bloomberg Pricing Power ETF
POWA
$183M
| $217K | ﹤0.01% |
3,890
+1,154
| +42% | +$63.2K |
|
5549
Sasol
SSL
$7.1B
| $217K | ﹤0.01% |
10,052
+5,231
| +109% | +$100K |
|
5550
Telecom Argentina
TEO
$5.96B
| $216K | ﹤0.01% |
19,038
+488
| +3% | +$4.89K |
|
Similar funds
UBS Group's Q4 2019 Portfolio in Review
As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.
By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
- UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
- UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
- UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
- UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
- UBS Group opened 808 new positions and closed 688 in Q4 2019.
- UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.
Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.